Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects

Mayumi Yamato, Takeshi Shiba, Tomomi Ide, Youhei Honda, Ken Ichi Yamada, Hiroyuki Tsutsui

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Stroke is a major cause of mortality and morbidity in hypertensive patients. This study investigated the effects of nifedipine, an L-type voltage-gated Ca 2+ channel blocker, on ischemic lesion volume after focal cerebral ischemia and reperfusion in rats. Rats were subjected to 1 h of transient middle cerebral artery occlusion (MCAO). At 2 days after MCAO, the rats were randomized into two groups that were fed either a normal control diet (n=10) or a nifedipine (0.001%) containing diet (n=11) for 2 weeks. Nifedipine treatment significantly reduced ischemic lesion volume (116.5±10.8 vs. 80.0±8.2 mm 3, P<0.05) without affecting body weight or blood pressure. It also decreased thiobarbituric-reactive substances, an index of lipid peroxide, (2.6±0.4 vs. 1.7±0.1 mol g -1 tissue, P<0.05) and increased glutathione peroxidase (54.9±4.7 vs. 70.9±6.4 U g -1 protein, P<0.05) and glutathione reductase activities (32.4±1.4 vs. 39.9±2.7 U g -1 protein, P<0.05) in the mitochondria from the ischemic hemispheres. These results suggest that nifedipine treatment can reduce ischemic lesion volume after focal cerebral ischemia, possibly because of the decrease in oxidative stress with an increase in antioxidant activities within the ischemic area.

Original languageEnglish
Pages (from-to)840-845
Number of pages6
JournalHypertension Research
Volume34
Issue number7
DOIs
Publication statusPublished - Jul 1 2011

Fingerprint

Nifedipine
Ischemia
Middle Cerebral Artery Infarction
Brain
Brain Ischemia
Diet
Glutathione Reductase
Lipid Peroxides
Therapeutics
Glutathione Peroxidase
Reperfusion
Mitochondria
Proteins
Oxidative Stress
Antioxidants
Stroke
Body Weight
Blood Pressure
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects. / Yamato, Mayumi; Shiba, Takeshi; Ide, Tomomi; Honda, Youhei; Yamada, Ken Ichi; Tsutsui, Hiroyuki.

In: Hypertension Research, Vol. 34, No. 7, 01.07.2011, p. 840-845.

Research output: Contribution to journalArticle

@article{f1d9c202d44b4113a727b2faa0054dae,
title = "Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects",
abstract = "Stroke is a major cause of mortality and morbidity in hypertensive patients. This study investigated the effects of nifedipine, an L-type voltage-gated Ca 2+ channel blocker, on ischemic lesion volume after focal cerebral ischemia and reperfusion in rats. Rats were subjected to 1 h of transient middle cerebral artery occlusion (MCAO). At 2 days after MCAO, the rats were randomized into two groups that were fed either a normal control diet (n=10) or a nifedipine (0.001{\%}) containing diet (n=11) for 2 weeks. Nifedipine treatment significantly reduced ischemic lesion volume (116.5±10.8 vs. 80.0±8.2 mm 3, P<0.05) without affecting body weight or blood pressure. It also decreased thiobarbituric-reactive substances, an index of lipid peroxide, (2.6±0.4 vs. 1.7±0.1 mol g -1 tissue, P<0.05) and increased glutathione peroxidase (54.9±4.7 vs. 70.9±6.4 U g -1 protein, P<0.05) and glutathione reductase activities (32.4±1.4 vs. 39.9±2.7 U g -1 protein, P<0.05) in the mitochondria from the ischemic hemispheres. These results suggest that nifedipine treatment can reduce ischemic lesion volume after focal cerebral ischemia, possibly because of the decrease in oxidative stress with an increase in antioxidant activities within the ischemic area.",
author = "Mayumi Yamato and Takeshi Shiba and Tomomi Ide and Youhei Honda and Yamada, {Ken Ichi} and Hiroyuki Tsutsui",
year = "2011",
month = "7",
day = "1",
doi = "10.1038/hr.2011.51",
language = "English",
volume = "34",
pages = "840--845",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects

AU - Yamato, Mayumi

AU - Shiba, Takeshi

AU - Ide, Tomomi

AU - Honda, Youhei

AU - Yamada, Ken Ichi

AU - Tsutsui, Hiroyuki

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Stroke is a major cause of mortality and morbidity in hypertensive patients. This study investigated the effects of nifedipine, an L-type voltage-gated Ca 2+ channel blocker, on ischemic lesion volume after focal cerebral ischemia and reperfusion in rats. Rats were subjected to 1 h of transient middle cerebral artery occlusion (MCAO). At 2 days after MCAO, the rats were randomized into two groups that were fed either a normal control diet (n=10) or a nifedipine (0.001%) containing diet (n=11) for 2 weeks. Nifedipine treatment significantly reduced ischemic lesion volume (116.5±10.8 vs. 80.0±8.2 mm 3, P<0.05) without affecting body weight or blood pressure. It also decreased thiobarbituric-reactive substances, an index of lipid peroxide, (2.6±0.4 vs. 1.7±0.1 mol g -1 tissue, P<0.05) and increased glutathione peroxidase (54.9±4.7 vs. 70.9±6.4 U g -1 protein, P<0.05) and glutathione reductase activities (32.4±1.4 vs. 39.9±2.7 U g -1 protein, P<0.05) in the mitochondria from the ischemic hemispheres. These results suggest that nifedipine treatment can reduce ischemic lesion volume after focal cerebral ischemia, possibly because of the decrease in oxidative stress with an increase in antioxidant activities within the ischemic area.

AB - Stroke is a major cause of mortality and morbidity in hypertensive patients. This study investigated the effects of nifedipine, an L-type voltage-gated Ca 2+ channel blocker, on ischemic lesion volume after focal cerebral ischemia and reperfusion in rats. Rats were subjected to 1 h of transient middle cerebral artery occlusion (MCAO). At 2 days after MCAO, the rats were randomized into two groups that were fed either a normal control diet (n=10) or a nifedipine (0.001%) containing diet (n=11) for 2 weeks. Nifedipine treatment significantly reduced ischemic lesion volume (116.5±10.8 vs. 80.0±8.2 mm 3, P<0.05) without affecting body weight or blood pressure. It also decreased thiobarbituric-reactive substances, an index of lipid peroxide, (2.6±0.4 vs. 1.7±0.1 mol g -1 tissue, P<0.05) and increased glutathione peroxidase (54.9±4.7 vs. 70.9±6.4 U g -1 protein, P<0.05) and glutathione reductase activities (32.4±1.4 vs. 39.9±2.7 U g -1 protein, P<0.05) in the mitochondria from the ischemic hemispheres. These results suggest that nifedipine treatment can reduce ischemic lesion volume after focal cerebral ischemia, possibly because of the decrease in oxidative stress with an increase in antioxidant activities within the ischemic area.

UR - http://www.scopus.com/inward/record.url?scp=79959997044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959997044&partnerID=8YFLogxK

U2 - 10.1038/hr.2011.51

DO - 10.1038/hr.2011.51

M3 - Article

C2 - 21562512

AN - SCOPUS:79959997044

VL - 34

SP - 840

EP - 845

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 7

ER -